Webinar Archive

Research Series

TBA

Elise Weerts, Ph.D.

Ethan Russo, MD

Allyn C. Howlett, Ph.D

Ryan McLaughlin, Ph.D

Andrea Hohmann, Ph.D

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Ethan Russo, MD

Limonene, THC, Herbal Synergy and the Entourage Effect

June 13, 2024, 1:00PM MT

Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]

Read More »

Allyn C. Howlett, Ph.D

How the CB1 cannabinoid receptor communicates within the cell via associated proteins

April 11, 2024, 1 PM MST

Dr. Allyn C. Howlett is a Professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Assistant Dean of WFU Graduate School Biomedical Programs, and Director of the Office of Postdoctoral Education. Dr. Howlett is an […]

Read More »

Ryan McLaughlin, Ph.D

From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure

March 14, 2024, 1 PM MST

Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain […]

Read More »

Andrea Hohmann, Ph.D

The therapeutic promise of non-addicting cannabinoid analgesics

February 2024

Andrea G. Hohmann is a Linda and Jack Gill Chair of Biomolecular Science and Professor of Psychological and Brain Sciences at Indiana University Bloomington. Dr. Hohmann received her Ph.D. from Brown University and completed postdoctoral training at NIMH and NIDCR in functional neuroanatomy and pain and neurosensory […]

Read More »
ICR Logo Icon PNG

Cassie Moore, Ph.D

Preclinical Assessment of Cannabinoid-Based Medications for Treatment of Multidimensional Opiod Withdrawal

January 2024

Cassie Moore, PhD is an Assistant Professor in the Division of Behavioral Biology at the Johns Hopkins University School of Medicine. Her research uses animal models to explore the balance between potential benefits and consequences of cannabinoid-based medications. Recent projects have been focused […]

Read More »
ICR Logo Icon PNG

Jane Metrik, Ph.D, Cannabis and Alcohol Co-Use and Comorbidity

December 2023

Jane Metrik, Ph.D., is Professor in the Departments of Behavioral and Social Sciences and Psychiatry and Human Behavior at Brown University based at the Center for Alcohol and Addiction Studies. She holds a joint appointment at the Providence VA Medical Center, as a research scientist and as a licensed clinical psychologist. Trained in the Joint […]

Read More »
ICR Logo Icon PNG

Tess Eidom PhD, PCQI, Assessing and Addressing Microbial Risks to Cannabis Patients and Consumers

October 2023

Tess Eidem earned her Ph.D. in Microbiology discovering novel antimicrobial compounds against bacterial pathogens, and she has continued to expand her knowledge in and outside of the lab, building a strong background in manufacturing, product safety and quality, and microbial detection and prevention measures with a focus on controlled environment agriculture (CEA) settings. Dr. […]

Read More »
ICR Logo Icon PNG

Ryan Vandrey, PhD., Experimental analysis of acute cannabis and cannabinoid effects in healthy adults

September 2023

Dr. Vandrey is an experimental psychologist with degrees from the University of Delaware (BA) and University of Vermont (PhD).  He is currently a Professor at the  Behavioral Pharmacology Research Unit (BPRU).  Dr. Vandrey’s research focuses primarily on the impact of route of administration, dose, and chemical composition of cannabis products on resultant drug effects […]

Read More »
ICR Logo Icon PNG

Dr. Jodi Gilman, Identification of THC Impairment Using Functional Brain Imaging

July 2023

Dr. Jodi Gilman is an Associate Professor in Psychiatry at Harvard Medical School and the Director of Neuroscience at the Massachusetts General Hospital Center for Addiction Medicine. She received her PhD in Neuroscience from Brown University. Dr. Gilman’s research uses multi-modal imaging, behavioral and cognitive testing to understand the biological, psychological, and clinical aspects […]

Read More »
ICR Logo Icon PNG

Dr. Tory Spindle, Using human laboratory studies to advance cannabis regulatory science

May 2023

Dr. Tory Spindle obtained his PhD in Experimental Health Psychology from Virginia Commonwealth University. Broadly, Dr. Spindle utilizes human laboratory studies to characterize the behavioral pharmacology of cannabis and individual cannabis constituents. His research seeks to understand how factors such as route of administration (oral, vaped, smoked, topical), dose, product formulation/chemical composition profile, and […]

Read More »
ICR Logo Icon PNG

Dr. Jessica S. Kruger, The Alphabet Soup of Alternative Cannabinoids

April 2023

Jessica S. Kruger, PhD, MCHES, is a health educator whose research focuses on consumption and addictive behaviors, health behavior decision-making and pedagogy in public health. She collaborates with a wide variety of community-based organizations and advises students at the Lighthouse Free Medical Clinic and the Seneca-Babcock Community Center, both in the Western New York […]

Read More »
ICR Logo Icon PNG

Dr. Adie Rae Wilson-Poe, The Unintended Negative Impact of Adult-Use Cannabis Legalization on the Wellbeing of Medical Cannabis Patients

March 2023

Dr. Adie Rae Wilson-Poe : “The Unintended Negative Impact of Adult-Use Cannabis Legalization on the Wellbeing of Medical Cannabis Patients” Dr. Wilson-Poe received her BS in Psychology and her PhD in Neuroscience from Washington State University, where she focused on the pain-relieving properties of opioids and cannabinoids.

Adie followed up on this training by taking […]

Read More »